Cohort study

Tse, G. ., Emmanuel, B. ., Ariti, C. ., Bafadhel, M. ., Papi, A. ., Carter, V. ., … Price, D. . (2023). A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. Int J Chron Obstruct Pulmon Dis, 18, 2565–2580. http://doi.org/10.2147/copd.s433326
Bojke, C. ., Capucci, S. ., Haase, C. L., Hartvig, N. V., Matthiessen, S. ., Morgen, C. S., … Pearson-Stuttard, J. . (2023). Association between weight loss and health care resource utilization in adults living with obesity: Evidence from a UK primary care database. Diabetes Obes Metab. http://doi.org/10.1111/dom.15256
Syed, U. ., Subramanian, A. ., Wraith, D. C., Lord, J. M., McGee, K. ., Ghokale, K. ., … Haroon, S. . (2023). Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care. BMC Med, 21, 363. http://doi.org/10.1186/s12916-023-03049-5
Alkabbani, W. ., Shah, B. R., Zongo, A. ., Eurich, D. T., Alsabbagh, M. W., & Gamble, J. M. (2023). Post-initiation predictors of discontinuation of the sodium-glucose cotransporter-2 inhibitors: A comparative cohort study from the United Kingdom. Diabetes Obes Metab. http://doi.org/10.1111/dom.15241
Abrahami, D. ., D’Andrea, E. ., Yin, H. ., Kim, S. C., Paik, J. M., Wexler, D. ., … Patorno, E. . (2023). Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes Obes Metab. http://doi.org/10.1111/dom.15196
Ayele, H. T., Reynier, P. ., Azoulay, L. ., Platt, R. W., Cabaussel, J. ., Benayoun, S. ., & Filion, K. B. (2023). The Cardiovascular Safety of 5-Alpha-Reductase Inhibitors Among Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Am J Med. http://doi.org/10.1016/j.amjmed.2023.06.021
van Hulten, V. ., Driessen, J. H. M., Starup-Linde, J. K., Al-Mashhadi, Z. K., Viggers, R. ., Klungel, O. H., … van den Bergh, J. P. (2023). The associations of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors as add-on to metformin with fracture risk in patients with type 2 diabetes mellitus. Diabetes Obes Metab. http://doi.org/10.1111/dom.15220
MedSci, K. K. F., Schnecke, V. ., Haase, C. L., Harder-Lauridsen, N. M., Rathor, N. ., Sommer, K. ., & Morgen, C. S. (2023). Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database. Diabetes Obes Metab. http://doi.org/10.1111/dom.15154
Davies, M. J., Alibegovic, A. C., Jensen, A. B., Munikrishnappa, R. ., Nordsborg, R. B., & Braae, U. C. (2023). Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England. Diabetes Obes Metab. http://doi.org/10.1111/dom.15165
Warren-Gash, C. ., Davidson, J. A., Strongman, H. ., Herrett, E. ., Smeeth, L. ., Breuer, J. ., & Banerjee, A. . (2023). Severe COVID-19 outcomes by cardiovascular risk profile in England in 2020: a population-based cohort study. Lancet Reg Health Eur, 27, 100604. http://doi.org/10.1016/j.lanepe.2023.100604